HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Yi Yu Selected Research

Graphite

1/2022The Inhibition of SARS-CoV-2 3CL Mpro by Graphene and Its Derivatives from Molecular Dynamics Simulations.
7/2021Rapid and unamplified identification of COVID-19 with morpholino-modified graphene field-effect transistor nanosensor.
1/2020Dual-Aptamer Modified Graphene Field-Effect Transistor Nanosensor for Label-Free and Specific Detection of Hepatocellular Carcinoma-Derived Microvesicles.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Yi Yu Research Topics

Disease

66Neoplasms (Cancer)
11/2022 - 03/2005
12Inflammation (Inflammations)
06/2022 - 02/2005
12Ovarian Neoplasms (Ovarian Cancer)
01/2021 - 07/2011
10Neoplasm Metastasis (Metastasis)
05/2022 - 10/2012
8Infections
01/2021 - 06/2010
8Hepatocellular Carcinoma (Hepatoma)
01/2020 - 01/2014
7COVID-19
05/2022 - 01/2021
7Stomach Neoplasms (Stomach Cancer)
01/2018 - 03/2005
6Breast Neoplasms (Breast Cancer)
11/2021 - 10/2002
6Macular Degeneration (Age-Related Maculopathy)
10/2015 - 10/2011
5Chronic Renal Insufficiency
01/2021 - 10/2016
5Atrial Fibrillation
01/2020 - 01/2015
5Pain (Aches)
12/2019 - 06/2014
4Hypertension (High Blood Pressure)
01/2021 - 04/2006
4Diabetes Mellitus
01/2021 - 04/2006
4Carcinoma (Carcinomatosis)
09/2020 - 02/2015
4Renal Cell Carcinoma (Grawitz Tumor)
01/2020 - 12/2014
4Fibrosis (Cirrhosis)
10/2019 - 01/2017
4Carcinogenesis
01/2019 - 08/2013
4Atherosclerosis
11/2018 - 07/2013
4Substance-Related Disorders (Drug Abuse)
09/2017 - 06/2008
4Dehydration (Water Stress)
01/2016 - 11/2013
4Opioid-Related Disorders (Opiate Addiction)
08/2010 - 12/2006
3Myocardial Infarction
01/2022 - 06/2012
3Inflammatory Bowel Diseases (Inflammatory Bowel Disease)
11/2021 - 01/2017
3Nasopharyngeal Carcinoma
01/2021 - 06/2012
3Heart Failure
01/2021 - 04/2006
3Colorectal Neoplasms (Colorectal Cancer)
01/2021 - 01/2015
3Uterine Cervical Neoplasms (Cancer of the Cervix)
01/2021 - 04/2017
3Wounds and Injuries (Trauma)
12/2020 - 06/2012
3Infertility (Sterility)
05/2020 - 12/2010
3Primary Ovarian Insufficiency
05/2020 - 12/2010
3Prostatic Neoplasms (Prostate Cancer)
01/2020 - 12/2007
3Proteus Syndrome
01/2018 - 12/2015
3Cardiovascular Diseases (Cardiovascular Disease)
02/2016 - 05/2014
3Obesity
02/2016 - 01/2014
3Alcoholism (Alcohol Abuse)
01/2015 - 06/2008
3Parkinson Disease (Parkinson's Disease)
02/2008 - 04/2004
2Shock
08/2022 - 09/2019
2Dyspepsia (Indigestion)
01/2022 - 01/2022
2Thrombosis (Thrombus)
01/2022 - 01/2017
2Pancreatic Neoplasms (Pancreatic Cancer)
01/2022 - 11/2019
2Neuroinflammatory Diseases
01/2022 - 01/2022
2Squamous Cell Carcinoma (Epidermoid Carcinoma)
10/2021 - 05/2019
2Acute Kidney Injury (Acute Renal Failure)
09/2021 - 01/2017
2Hyperkalemia
09/2021 - 01/2021
2Hypotension (Low Blood Pressure)
09/2021 - 01/2021

Drug/Important Bio-Agent (IBA)

31Proteins (Proteins, Gene)FDA Link
05/2022 - 09/2002
13Biomarkers (Surrogate Marker)IBA
01/2022 - 07/2015
12Pharmaceutical PreparationsIBA
12/2021 - 06/2014
11Messenger RNA (mRNA)IBA
01/2022 - 10/2005
9MiransertibIBA
01/2021 - 01/2015
8MicroRNAs (MicroRNA)IBA
11/2021 - 08/2013
6Biological ProductsIBA
05/2022 - 11/2006
6Arginine (L-Arginine)FDA Link
05/2022 - 07/2013
6AntibodiesIBA
05/2022 - 12/2010
6ArginaseIBA
05/2022 - 07/2013
6Phosphotransferases (Kinase)IBA
01/2021 - 02/2008
6CytokinesIBA
11/2020 - 06/2010
6LigandsIBA
10/2020 - 11/2006
5VaccinesIBA
05/2022 - 07/2011
5AntigensIBA
01/2021 - 12/2010
5Cocaine (Cocaine HCl)IBA
08/2010 - 12/2006
4Histones (Histone)IBA
01/2022 - 12/2007
4LipidsIBA
01/2022 - 04/2017
4Competitive Endogenous RNAIBA
01/2022 - 01/2018
4Circular RNAIBA
10/2021 - 01/2018
4AlbuminsIBA
09/2021 - 01/2021
4chemotactic factor inactivatorIBA
07/2015 - 02/2011
3GraphiteIBA
01/2022 - 01/2020
3RNA (Ribonucleic Acid)IBA
07/2021 - 05/2019
3Sirolimus (Rapamycin)FDA Link
01/2021 - 01/2014
3Cisplatin (Platino)FDA LinkGeneric
01/2021 - 04/2017
3Angiotensin Receptor AntagonistsIBA
01/2021 - 06/2012
3Leucine (L-Leucine)FDA Link
01/2020 - 02/2008
3Plant ExtractsIBA
01/2020 - 04/2017
3Follicle Stimulating Hormone (Follitropin)FDA Link
11/2019 - 11/2018
3Phosphoric Monoester Hydrolases (Phosphatases)IBA
10/2019 - 01/2019
3Analgesics (Analgesic Drugs)IBA
03/2019 - 01/2018
3Peptides (Polypeptides)IBA
11/2018 - 01/2016
3Glucose (Dextrose)FDA LinkGeneric
11/2018 - 06/2013
3DNA (Deoxyribonucleic Acid)IBA
11/2018 - 11/2006
3platelet activating factor receptorIBA
10/2018 - 05/2014
3Apolipoproteins E (ApoE)IBA
01/2018 - 07/2013
3EnzymesIBA
01/2016 - 01/2014
3ErbB Receptors (EGF Receptor)IBA
09/2014 - 10/2002
3AutoantibodiesIBA
09/2011 - 12/2010
2Immunoglobulin G (IgG)IBA
05/2022 - 01/2021
2Protein Isoforms (Isoforms)IBA
05/2022 - 02/2015
2Domperidone (Domperidon)IBA
01/2022 - 01/2022
2LipopolysaccharidesIBA
01/2022 - 01/2017
2Doxorubicin (Adriamycin)FDA LinkGeneric
12/2021 - 03/2014
2CreatinineIBA
09/2021 - 12/2019
2Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
07/2021 - 12/2014
2Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA
01/2021 - 01/2021

Therapy/Procedure

21Therapeutics
05/2022 - 04/2013
6Drug Therapy (Chemotherapy)
01/2022 - 01/2018
3Immunotherapy
01/2021 - 01/2018
3Catheter Ablation
01/2020 - 10/2019
2Kidney Transplantation
01/2022 - 05/2014